Study Evaluating Safety And Tolerability Of Meningococcal B Rlp2086 Vaccine In Healthy Adults

NCT00879814 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningitis, Meningococcal

Interventions

BIOLOGICAL: rLP2086 vaccine or control
BIOLOGICAL: rLP2086 vaccine or control
BIOLOGICAL: rLP2086 vaccine or control
BIOLOGICAL: rLP2086 vaccine or control

Sponsor

Pfizer